We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Zymo Research Corp, a California-based life science reagent company and Opentrons Labworks, Inc, makers of affordable and easy-to-use lab robotics, have partnered to create a robust engine for
US-based molecular diagnostics company Enzo Biochem has launched a new initiative, dubbed ‘Comprehensive COVID-19 Program’ to incorporate its advanced molecular diagnostic products. The company’s COVID-19 Program encompasses its
US-based biotechnology company Applied BioCode introduces BioCode SARS-CoV-2 Assay, a multiplex nucleic acid assay for the qualitative detection of SARS-CoV-2 nucleic acids in nasopharyngeal swabs and bronchoalveolar lavage.
IntraOp Medical, a provider of portable electron-beam therapy, has enrolled first patient in to the Cosmopolitan Trial, a randomised study of radiation therapy for breast cancer. Cosmopolitan Trial
Axalta (NYSE: AXTA), a leading global supplier of liquid and powder coatings, today announced that it has increased the supply of its Voltatex electrical insulating resins to ensure its medical device
Swedish Orphan Biovitrum AB (publ) (Sobi™) has today announced the launch by its affiliate, Florio GmbH, of Florio®, a digital medical device designed with the aim to improve
US-based medical device company Trividia Health has unveiled its plans to launch a new diagnostic test kit to enable the detection of SARS-CoV-2 virus. The launch of SARS-CoV-2
Swiss healthcare firm Roche has received the US Food and Drug Administration (FDA) approval for the cobas HPV test, used on its fully automated, high-throughput cobas 6800/8800 Systems.
Vuzix® Corporation (NASDAQ: VUZI), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, together with Librestream Technologies Inc., a leading provider of augmented reality enterprise solutions,
Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) today announced the signing of an Agreement with Stony Brook University Hospital (the “Hospital”) to validate and